Free Trial

STERIS plc (NYSE:STE) Shares Bought by Perpetual Ltd

STERIS logo with Medical background

Perpetual Ltd lifted its position in shares of STERIS plc (NYSE:STE - Free Report) by 9.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,571 shares of the medical equipment provider's stock after purchasing an additional 3,437 shares during the period. Perpetual Ltd's holdings in STERIS were worth $9,121,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. VisionPoint Advisory Group LLC bought a new stake in shares of STERIS in the 4th quarter worth approximately $34,000. Pingora Partners LLC purchased a new position in STERIS during the 4th quarter valued at $37,000. Glassman Wealth Services bought a new position in STERIS in the 4th quarter worth $38,000. Spire Wealth Management lifted its position in shares of STERIS by 88.0% in the 4th quarter. Spire Wealth Management now owns 203 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 95 shares during the period. Finally, AdvisorNet Financial Inc boosted its stake in shares of STERIS by 144.9% during the 4th quarter. AdvisorNet Financial Inc now owns 311 shares of the medical equipment provider's stock valued at $68,000 after purchasing an additional 184 shares in the last quarter. 94.69% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on STE. JMP Securities reissued a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, May 9th. StockNews.com upgraded STERIS from a "hold" rating to a "buy" rating in a research report on Saturday, June 15th. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Friday, May 10th. Finally, Piper Sandler restated a "neutral" rating and set a $225.00 target price (up previously from $220.00) on shares of STERIS in a report on Friday, May 10th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $241.60.


View Our Latest Stock Report on STE

STERIS Stock Down 0.4 %

Shares of NYSE STE traded down $0.90 during trading on Friday, reaching $218.41. The company had a trading volume of 832,071 shares, compared to its average volume of 495,368. STERIS plc has a 12-month low of $195.47 and a 12-month high of $254.00. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49. The business's 50-day moving average is $218.42 and its 200 day moving average is $220.38. The stock has a market cap of $21.59 billion, a PE ratio of 57.18 and a beta of 0.85.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.41 by $0.17. The company had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.41 billion. STERIS had a net margin of 6.95% and a return on equity of 13.73%. STERIS's revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.30 EPS. As a group, equities analysts forecast that STERIS plc will post 9.24 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be issued a $0.52 dividend. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a yield of 0.95%. STERIS's payout ratio is currently 54.45%.

Insider Activity at STERIS

In other STERIS news, VP Renato Tamaro sold 1,154 shares of STERIS stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total value of $267,312.56. Following the completion of the sale, the vice president now owns 6,677 shares of the company's stock, valued at approximately $1,546,660.28. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, VP Renato Tamaro sold 1,154 shares of the firm's stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total transaction of $267,312.56. Following the sale, the vice president now owns 6,677 shares of the company's stock, valued at approximately $1,546,660.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Cary L. Majors sold 2,024 shares of STERIS stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total transaction of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares of the company's stock, valued at $2,639,085.97. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,762 shares of company stock valued at $1,798,477. 1.14% of the stock is owned by corporate insiders.

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

See Also

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Should you invest $1,000 in STERIS right now?

Before you consider STERIS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.

While STERIS currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

CPI News Breakdown: Key Market Moves to Follow
Understanding Oversold Stocks
Inside Pelosi’s Latest Stock Moves

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines